Cell-Based Therapy for Ischemic Heart Disease: A Clinical Update

Annals of Thoracic Surgery

Volumn 88, Issue 5, 2009, Pages 1714-1722

  Herrmann, Jeremy L ^a   Abarbanell, Aaron M ^a   Weil, Brent R ^a   Wang, Yue ^a   Wang, Meijing ^a   Tan, Jiangning ^a   Meldrum, Daniel R ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

AUTOLOGOUS STEM CELL TRANSPLANTATION; CELL DIFFERENTIATION; CELL SURVIVAL; CELL TYPE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CORONARY ARTERY BYPASS GRAFT; EMBRYONIC STEM CELL; FOLLOW UP; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART PROTECTION; HEMATOPOIETIC STEM CELL; HUMAN; INFORMATION RETRIEVAL; ISCHEMIC HEART DISEASE; MEDLINE; MESENCHYMAL STEM CELL; META ANALYSIS; METHODOLOGY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVASCULARIZATION; REVIEW; RISK REDUCTION; STEM CELL TRANSPLANTATION; SYSTEMATIC REVIEW; HEART MUSCLE ISCHEMIA;

CLINICAL TRIALS AS TOPIC; HUMANS; MYOCARDIAL ISCHEMIA; STEM CELL TRANSPLANTATION;

EID: 70449704532     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2009.05.079     Document Type: Review

References (73)

1. Toma C., Pittenger M.F., Cahill K.S., Byrne B.J., and Kessler P.D. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 105 (2002) 93-98
2. Chang S.A., Lee E.J., Kang H.J., et al. Impact of myocardial infarct proteins and oscillating pressure on the differentiation of mesenchymal stem cells: effect of acute myocardial infarction on stem cell differentiation. Stem Cells 26 (2008) 1901-1912
3. Rose R.A., Jiang H., Wang X., et al. Bone marrow-derived mesenchymal stromal cells express cardiac-specific markers, retain the stromal phenotype and do not become functional cardiomyocytes in vitro. Stem Cells 26 (2008) 2884-2892
4. Arminan A., Gandia C., Bartual M.C., et al. Cardiac differentiation is driven by NKX2.5 and GATA4 nuclear translocation in tissue-specific mesenchymal stem cells. Stem Cells Dev 18 (2009) 907-918
5. US National Institutes of Health. http://www.clinicaltrials.gov Accessed October 1, 2008
6. Shintani S., Murohara T., Ikeda H., et al. Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 103 (2001) 2776-2779
7. Barbash I.M., Chouraqui P., Baron J., et al. Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution. Circulation 108 (2003) 863-868
8. Kucia M., Dawn B., Hunt G., et al. Cells expressing early cardiac markers reside in the bone marrow and are mobilized into the peripheral blood after myocardial infarction. Circ Res 95 (2004) 1191-1199
9. Wojakowski W., Tendera M., Michalowska A., et al. Mobilization of CD34/CXCR4+, CD34/CD117+, c-met+ stem cells, and mononuclear cells expressing early cardiac, muscle, and endothelial markers into peripheral blood in patients with acute myocardial infarction. Circulation 110 (2004) 3213-3220
10. Gnecchi M., He H., Noiseux N., et al. Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. FASEB J 20 (2006) 661-669
11. Crisostomo P.R., Abarbanell A.M., Wang M., et al. Embryonic stem cells attenuate myocardial dysfunction and inflammation after surgical global ischemia via paracrine actions. Am J Physiol Heart Circ Physiol 295 (2008) H1726-H1735
12. Gnecchi M., Zhang Z., Ni A., and Dzau V.J. Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res 103 (2008) 1204-1219
13. Kinnaird T., Stabile E., Burnett M.S., et al. Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res 94 (2004) 678-685
14. Schachinger V., Erbs S., Elsasser A., et al. Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial. Eur Heart J 27 (2006) 2775-2783
15. Meyer G.P., Wollert K.C., Lotz J., et al. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial. Circulation 113 (2006) 1287-1294
16. Laflamme M.A., and Murry C.E. Regenerating the heart. Nat Biotechnol 23 (2005) 845-856
17. Scorsin M., Hagege A.A., Marotte F., et al. Does transplantation of cardiomyocytes improve function of infarcted myocardium?. Circulation 96 (1997) II-188-II-193
18. Min J.Y., Yang Y., Sullivan M.F., et al. Long-term improvement of cardiac function in rats after infarction by transplantation of embryonic stem cells. J Thorac Cardiovasc Surg 125 (2003) 361-369
19. Leor J., Gerecht S., Cohen S., et al. Human embryonic stem cell transplantation to repair the infarcted myocardium. Heart 93 (2007) 1278-1284
20. Nussbaum J., Minami E., Laflamme M.A., et al. Transplantation of undifferentiated murine embryonic stem cells in the heart: teratoma formation and immune response. FASEB J 21 (2007) 1345-1357
21. Laflamme M.A., Chen K.Y., Naumova A.V., et al. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol 25 (2007) 1015-1024
22. Caspi O., Huber I., Kehat I., et al. Transplantation of human embryonic stem cell-derived cardiomyocytes improves myocardial performance in infarcted rat hearts. J Am Coll Cardiol 50 (2007) 1884-1893
23. Abkowitz J.L., Catlin S.N., McCallie M.T., and Guttorp P. Evidence that the number of hematopoietic stem cells per animal is conserved in mammals. Blood 100 (2002) 2665-2667
24. Pittenger M.F., and Martin B.J. Mesenchymal stem cells and their potential as cardiac therapeutics. Circ Res 95 (2004) 9-20
25. Jackson K.A., Majka S.M., Wang H., et al. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest 107 (2001) 1395-1402
26. Murry C.E., Soonpaa M.H., Reinecke H., et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 428 (2004) 664-668
27. Conget P.A., and Minguell J.J. Phenotypical and functional properties of human bone marrow mesenchymal progenitor cells. J Cell Physiol 181 (1999) 67-73
28. Di Nicola M., Carlo-Stella C., Magni M., et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99 (2002) 3838-3843
29. Aggarwal S., and Pittenger M.F. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105 (2005) 1815-1822
30. Liechty K.W., MacKenzie T.C., Shaaban A.F., et al. Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nat Med 6 (2000) 1282-1286
31. Atoui R., Asenjo J.F., Duong M., et al. Marrow stromal cells as universal donor cells for myocardial regenerative therapy: their unique immune tolerance. Ann Thorac Surg 85 (2008) 571-579
32. Imanishi Y., Saito A., Komoda H., et al. Allogenic mesenchymal stem cell transplantation has a therapeutic effect in acute myocardial infarction in rats. J Mol Cell Cardiol 44 (2008) 662-671
33. Urbich C., and Dimmeler S. Endothelial progenitor cells: characterization and role in vascular biology. Circ Res 95 (2004) 343-353
34. Badorff C., Brandes R.P., Popp R., et al. Transdifferentiation of blood-derived human adult endothelial progenitor cells into functionally active cardiomyocytes. Circulation 107 (2003) 1024-1032
35. Gruh I., Beilner J., Blomer U., et al. No evidence of transdifferentiation of human endothelial progenitor cells into cardiomyocytes after coculture with neonatal rat cardiomyocytes. Circulation 113 (2006) 1326-1334
36. Roberts N., Xiao Q., Weir G., Xu Q., and Jahangiri M. Endothelial progenitor cells are mobilized after cardiac surgery. Ann Thorac Surg 83 (2007) 598-605
37. Oh H., Bradfute S.B., Gallardo T.D., et al. Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc Natl Acad Sci U S A 100 (2003) 12313-12318
38. Beltrami A.P., Barlucchi L., Torella D., et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 114 (2003) 763-776
39. Martin C.M., Ferdous A., Gallardo T., et al. Hypoxia-inducible factor-2alpha transactivates Abcg2 and promotes cytoprotection in cardiac side population cells. Circ Res 102 (2008) 1075-1081
40. Hierlihy A.M., Seale P., Lobe C.G., Rudnicki M.A., and Megeney L.A. The post-natal heart contains a myocardial stem cell population. FEBS Lett 530 (2002) 239-243
41. Laugwitz K.L., Moretti A., Lam J., et al. Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages. Nature 433 (2005) 647-653
42. Cai C.L., Liang X., Shi Y., et al. Isl1 identifies a cardiac progenitor population that proliferates prior to differentiation and contributes a majority of cells to the heart. Dev Cell 5 (2003) 877-889
43. Price M.J., Chou C.C., Frantzen M., et al. Intravenous mesenchymal stem cell therapy early after reperfused acute myocardial infarction improves left ventricular function and alters electrophysiologic properties. Int J Cardiol 111 (2006) 231-239
44. Melo L.G., Pachori A.S., Kong D., et al. Gene and cell-based therapies for heart disease. FASEB J 18 (2004) 648-663
45. Vulliet P.R., Greeley M., Halloran S.M., MacDonald K.A., and Kittleson M.D. Intra-coronary arterial injection of mesenchymal stromal cells and microinfarction in dogs. Lancet 363 (2004) 783-784
46. Freyman T., Polin G., Osman H., et al. A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction. Eur Heart J 27 (2006) 1114-1122
47. Smits P.C., van Geuns R.J., Poldermans D., et al. Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: clinical experience with six-month follow-up. J Am Coll Cardiol 42 (2003) 2063-2069
48. Abdel-Latif A., Bolli R., Tleyjeh I.M., et al. Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch Intern Med 167 (2007) 989-997
49. Lipinski M.J., Biondi-Zoccai G.G., Abbate A., et al. Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a collaborative systematic review and meta-analysis of controlled clinical trials. J Am Coll Cardiol 50 (2007) 1761-1767
50. Martin-Rendon E., Brunskill S., Doree C., et al. Stem cell treatment for acute myocardial infarction. Cochrane Database Syst Rev (2008) CD006536
51. Dill T., Schachinger V., Rolf A., et al. Intracoronary administration of bone marrow-derived progenitor cells improves left ventricular function in patients at risk for adverse remodeling after acute ST-segment elevation myocardial infarction: results of the Reinfusion of Enriched Progenitor cells And Infarct Remodeling in Acute Myocardial Infarction study (REPAIR-AMI) cardiac magnetic resonance imaging substudy. Am Heart J 157 (2009) 541-547
52. Stamm C., Kleine H.D., Choi Y.H., et al. Intramyocardial delivery of CD133+ bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: safety and efficacy studies. J Thorac Cardiovasc Surg 133 (2007) 717-725
53. Zhao Q., Sun Y., Xia L., et al. Randomized study of mononuclear bone marrow cell transplantation in patients with coronary surgery. Ann Thorac Surg 86 (2008) 1833-1840
54. Hendrikx M., Hensen K., Clijsters C., et al. Recovery of regional but not global contractile function by the direct intramyocardial autologous bone marrow transplantation: results from a randomized controlled clinical trial. Circulation 114 (2006) I101-I107
55. Ang K.L., Chin D., Leyva F., et al. Randomized, controlled trial of intramuscular injection of autologous bone marrow cells into scarred myocardium during CABG versus CABG alone. Nat Clin Pract Cardiovasc Med 5 (2008) 663-670
56. Rosova I., Dao M., Capoccia B., Link D., and Nolta J.A. Hypoxic preconditioning results in increased motility and improved therapeutic potential of human mesenchymal stem cells. Stem Cells 26 (2008) 2173-2182
57. Pasha Z., Wang Y., Sheikh R., et al. Preconditioning enhances cell survival and differentiation of stem cells during transplantation in infarcted myocardium. Cardiovasc Res 77 (2008) 134-142
58. Hahn J.Y., Cho H.J., Kang H.J., et al. Pre-treatment of mesenchymal stem cells with a combination of growth factors enhances gap junction formation, cytoprotective effect on cardiomyocytes, and therapeutic efficacy for myocardial infarction. J Am Coll Cardiol 51 (2008) 933-943
59. Yang J., Zhou W., Zheng W., et al. Effects of myocardial transplantation of marrow mesenchymal stem cells transfected with vascular endothelial growth factor for the improvement of heart function and angiogenesis after myocardial infarction. Cardiology 107 (2007) 17-29
60. Cheng Z., Ou L., Zhou X., et al. Targeted migration of mesenchymal stem cells modified with CXCR4 gene to infarcted myocardium improves cardiac performance. Mol Ther 16 (2008) 571-579
61. Mangi A.A., Noiseux N., Kong D., et al. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 9 (2003) 1195-1201
62. Tang Y.L., Tang Y., Zhang Y.C., et al. Improved graft mesenchymal stem cell survival in ischemic heart with a hypoxia-regulated heme oxygenase-1 vector. J Am Coll Cardiol 46 (2005) 1339-1350
63. Thompson R.B., Parsa C.J., van den Bos E.J., et al. Video-assisted thoracoscopic transplantation of myoblasts into the heart. Ann Thorac Surg 78 (2004) 303-307
64. Ott H.C., Brechtken J., Swingen C., et al. Robotic minimally invasive cell transplantation for heart failure. J Thorac Cardiovasc Surg 132 (2006) 170-173
65. Schachinger V., Assmus B., Britten M.B., et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial. J Am Coll Cardiol 44 (2004) 1690-1699
66. Kang H.J., Lee H.Y., Na S.H., et al. Differential effect of intracoronary infusion of mobilized peripheral blood stem cells by granulocyte colony-stimulating factor on left ventricular function and remodeling in patients with acute myocardial infarction versus old myocardial infarction: the MAGIC Cell-3-DES randomized, controlled trial. Circulation 114 (2006) I145-I151
67. Lunde K., Solheim S., Forfang K., et al. Anterior myocardial infarction with acute percutaneous coronary intervention and intracoronary injection of autologous mononuclear bone marrow cells: safety, clinical outcome, and serial changes in left ventricular function during 12-months' follow-up. J Am Coll Cardiol 51 (2008) 674-676
68. Heeschen C., Lehmann R., Honold J., et al. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation 109 (2004) 1615-1622
69. Tse H.F., Thambar S., Kwong Y.L., et al. Prospective randomized trial of direct endomyocardial implantation of bone marrow cells for treatment of severe coronary artery diseases (PROTECT-CAD trial). Eur Heart J 28 (2007) 2998-3005
70. Yao K., Huang R., Qian J., et al. Administration of intracoronary bone marrow mononuclear cells on chronic myocardial infarction improves diastolic function. Heart 94 (2008) 1147-1153
71. Assmus B., Fischer-Rasokat U., Honold J., et al. Transcoronary transplantation of functionally competent BMCs is associated with a decrease in natriuretic peptide serum levels and improved survival of patients with chronic postinfarction heart failure: results of the TOPCARE-CHD Registry. Circ Res 100 (2007) 1234-1241
72. Menasche P., Alfieri O., Janssens S., et al. The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. Circulation 117 (2008) 1189-1200
73. Veltman C.E., Soliman O.I., Geleijnse M.L., et al. Four-year follow-up of treatment with intramyocardial skeletal myoblasts injection in patients with ischaemic cardiomyopathy. Eur Heart J 29 (2008) 1386-1396